Join the Percutaneous Coronary Intervention group to help and get support from people like you.
Percutaneous Coronary Intervention News
Racial, Ethnic, Economic Disparities Identified in Adoption of PCI Services
TUESDAY, July 9, 2024 – Hospitals serving communities with large proportions of Black and Hispanic residents and with residential segregation are less likely to adopt percutaneous coronary...
Radial Access for Percutaneous Coronary Intervention Now Dominant Method
THURSDAY, May 16, 2024 – Use of radial access for percutaneous coronary intervention (PCI) increased 2.8-fold in the United States between 2013 and 2022, according to a study presented at the annual...
FDA Approves Antiplatelet Agent Kengreal (cangrelor) as Adjunct to Percutaneous Coronary Intervention
June 22, 2015 – The U.S. Food and Drug Administration today approved Kengreal (cangrelor), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries,...